The vitamin K epoxide reductase complex 1 gene (VKORC1) is commonly assessed to predict warfarin sensitivity. In this study, a new nested allele-specific multiplex polymerase chain reaction (PCR) method that can simultaneously identify single nucleotide polymorphisms (SNPs) at VKORC1 381, 861, 5808, and 9041 for haplotype analysis was developed and validated. Extracted DNA was amplified in the first PCR DNA, which was optimized by investigating the effects of varying the primer concentrations, annealing temperature, magnesium chloride concentration, enzyme concentration, and the amount of DNA template. The amplification products produced from the first round of PCR were used as templates for a second PCR amplification in which both mutant a...
Genetic testing for common variants in the CYP2C9 and VKORC1 genes may provide useful clinical infor...
Warfarin therapy is complicated by its large inter-individual and intra-individual variability. Both...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Background: Warfarin has very narrow therapeutic windows and large individual variability. Genetic v...
AbstractWarfarin is a commonly prescribed oral anticoagulant used for prophylaxis and treatment of d...
Polymorphisms in vitamin K epoxide reductase complex subunit 1 (VKORC1) gene lead to interindividual...
Warfarin is a commonly-prescribed anticoagulant used to treat and prevent thromboembolic events. The...
Warfarin is an anticoagulant prescribed in the treatment and prevention of thrombosis. Variation in ...
Background. Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene encodes a key enzyme with mu...
Cilj osebnostne medicine je izboljšati učinkovitost zdravljenja in zmanjšati pojav neželenih učinkov...
Single nucleotide polymorphisms in the vitamin K epoxide reductase (VKOR) gene have been successfull...
The aim of this study was to investigate the possible effects of EPHX1 and VKORC1L1 polymorphisms on...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
The genetic factors are determinants in required dosage changes of warfarin among which are polymorp...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Genetic testing for common variants in the CYP2C9 and VKORC1 genes may provide useful clinical infor...
Warfarin therapy is complicated by its large inter-individual and intra-individual variability. Both...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Background: Warfarin has very narrow therapeutic windows and large individual variability. Genetic v...
AbstractWarfarin is a commonly prescribed oral anticoagulant used for prophylaxis and treatment of d...
Polymorphisms in vitamin K epoxide reductase complex subunit 1 (VKORC1) gene lead to interindividual...
Warfarin is a commonly-prescribed anticoagulant used to treat and prevent thromboembolic events. The...
Warfarin is an anticoagulant prescribed in the treatment and prevention of thrombosis. Variation in ...
Background. Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene encodes a key enzyme with mu...
Cilj osebnostne medicine je izboljšati učinkovitost zdravljenja in zmanjšati pojav neželenih učinkov...
Single nucleotide polymorphisms in the vitamin K epoxide reductase (VKOR) gene have been successfull...
The aim of this study was to investigate the possible effects of EPHX1 and VKORC1L1 polymorphisms on...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
The genetic factors are determinants in required dosage changes of warfarin among which are polymorp...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Genetic testing for common variants in the CYP2C9 and VKORC1 genes may provide useful clinical infor...
Warfarin therapy is complicated by its large inter-individual and intra-individual variability. Both...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...